The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
A prospective randomized crossover trial of systemic chemotherapy in patients with low-grade mucinous appendiceal adenocarcinoma.
 
John Paul Y.C. Shen
Stock and Other Ownership Interests - Agios; Syndax; Syndax
Consulting or Advisory Role - Engine Biosciences
Research Funding - Celsius Therapeutics; Celsius Therapeutics
 
Abdelrahman M.G. Yousef
No Relationships to Disclose
 
Fadl A. Zeineddine
No Relationships to Disclose
 
Mohammad A. Zeineddine
No Relationships to Disclose
 
Karen A. Beaty
No Relationships to Disclose
 
Lisa Scofield
No Relationships to Disclose
 
Rebecca Slack Tidwell
No Relationships to Disclose
 
Safia Rafeeq
No Relationships to Disclose
 
Nicholas James Hornstein
No Relationships to Disclose
 
Elizabeth A Lano
No Relationships to Disclose
 
Cathy Eng
Consulting or Advisory Role - Bayer Health; GlaxoSmithKline; HalioDx; Janssen Oncology; natera
Research Funding - Elevar Therapeutics (Inst); Hutchison China Meditech (Inst)
(OPTIONAL) Uncompensated Relationships - Merck (Inst); Pfizer (Inst)
 
Aurelio Matamoros
No Relationships to Disclose
 
Wai Chin Foo
No Relationships to Disclose
 
Abhineet Uppal
No Relationships to Disclose
 
Christopher Scally
No Relationships to Disclose
 
Paul F. Mansfield
Stock and Other Ownership Interests - Amgen; LabCorp; Stryker
Patents, Royalties, Other Intellectual Property - Royalties for up to date
 
Melissa Taggart
No Relationships to Disclose
 
Kanwal Pratap Singh Raghav
Consulting or Advisory Role - AstraZeneca; Bayer; Daiichi Sankyo; Eisai; Seagen
Speakers' Bureau - Bayer
Research Funding - Bayer (Inst); Daiichi Sankyo/Astra Zeneca (Inst); Guardant Health (Inst); HiberCell (Inst); Merck Serono (Inst); Roche/Genentech (Inst)
 
Michael J. Overman
Consulting or Advisory Role - 3D Medicines; Array BioPharma; Bristol-Myers Squibb; Eisai; Gritstone Bio; Janssen; Janssen; MedImmune; Merck; Novartis; Pfizer; Pfizer; Promega; Roche/Genentech; Spectrum Pharmaceuticals
Research Funding - Bristol-Myers Squibb; MedImmune; Merck; Roche
 
Keith F. Fournier
No Relationships to Disclose